Newsletter | November 12, 2025

11.12.25 -- How NK Cell Therapies Are Poised For Breakthroughs In Cancer

SPONSOR

Webinar: Unpacking pDNA processes: Capacity, complexity, and cutting-edge solutions

Plasmid DNA demand is exploding—driven by breakthroughs in gene therapy, mRNA vaccines, and cell therapies. But scaling production fast and flawlessly is no easy feat. Join experts from Cytiva, Bionova, and industry leaders as they reveal how flexible facilities, smart process innovations, and real-world lessons can help you scale pDNA manufacturing efficiently and stay ahead of growing therapeutic demand. Click here to learn more.

FOCUS ON TRANSLATIONAL RESEARCH

How NK Cell Therapies Are Poised For Breakthroughs In Cancer

In this first segment of our Cell & Gene LiveBuilding the Future of Cancer Immunotherapy Through Allogeneic NK Cell Innovation, expert panelists highlight how natural killer (NK) cell therapies are showing promising results in cancer treatment with compelling patient improvements and safety. Hear personal success stories and the unique advantages of NK cells, especially their potential for scalable, off-the-shelf treatments that could broaden access and reduce costs.

Viral Gene Therapy: Reducing Costs To Improve Patient Access

Gene therapy is revolutionizing medicine with its potential to cure genetic disorders. As approvals rise, so do concerns about accessibility, with million-dollar price tags limiting patient access.

Cell Collection Basics For The Transplant And CGT Industries

Breakthroughs in CAR T-cell and stem cell therapies depend on mastering cellular collection. Understanding these fundamentals is vital for advancing treatment efficacy and patient outcomes.

QualTrak Real-Time PCR And Digital PCR Ecosystem For Biologics Development

A vendor who provides high-quality qPCR and dPCR products—assays, reagents, and instruments for analysis—is vital for the success of biologics development.

Dissecting Cellular Composition Using Single-Cell Multiomics

Hear from Dr. Fabio Luciani, Professor and Senior Researcher in Systems Immunology at the School of Medical Sciences and the Kirby Institute at UNSW Sydney about his recent research.

Efficient, Large-Scale Virus-Like Particle Manufacturing For Gene Editing

Discover how flow electroporation streamlines VLP manufacturing for gene editing. This poster highlights efficient, scalable production with high yields and consistent gene-editing potency.

Improved Cell Viability For Multi-Day Cell-Based Assays

Ensure consistent cell health and assay reliability with controlled temperature and gas conditions. Assimilate how microplate readers with gas mixers enhance cell viability in live cell-based assays.

Background-Free Analysis Of Mouse TILs

Syngeneic mouse tumor models are crucial for immunotherapy research, but variability in TILs and nonspecific binding complicates analysis. Uncover how blocking reagents help, but make the process more labor-intensive.

SPONSOR

Join Jon O'Connell and experts on this Cell & Gene Live event, exploring whether minimum viability can help gene therapy developers make smarter sourcing decisions — from research-grade production through clinical and commercial phases, where cost and quality can make or break a product. Registration is free with support from Roche CustomBiotech.

TRANSLATIONAL RESEARCH SOLUTIONS

Immune Challenge Models For Early Drug Development - CHDR

Cell Therapy: Streamline The Path From Discovery To Commercialization - Thermo Fisher Scientific

Accelerate Innovation In Life Sciences And Diagnostics - Invetech

Liquid Biopsy: Accelerate Your Circulating Biomarker Research - QIAGEN

Connect With Cell & Gene: